文献
J-GLOBAL ID:201702239986914581
整理番号:17A1118294
新規ジペプチジルペプチダーゼ-4阻害剤,evogliptin(DA 1229)の薬物動態および薬力学に対する腎機能障害の影響【Powered by NICT】
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229)
著者 (10件):
Oh Jaeseong
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Korea)
,
Kim Andrew HyoungJin
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Korea)
,
Lee SeungHwan
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Korea)
,
Cho Hyunjeong
(Department of Internal Medicine, Seoul National University College of Medicine and Hospital, Seoul, Korea)
,
Kim Yon Su
(Department of Internal Medicine, Seoul National University College of Medicine and Hospital, Seoul, Korea)
,
Bahng Mi Young
(Department of Product Development, Dong-A ST Co. Ltd, Seoul, Korea)
,
Yoon Seo Hyun
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Korea)
,
Cho Joo-Youn
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Korea)
,
Jang In-Jin
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Korea)
,
Yu Kyung-Sang
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Korea)
資料名:
Diabetes Obesity & Metabolism
(Diabetes Obesity & Metabolism)
巻:
19
号:
2
ページ:
294-298
発行年:
2017年
JST資料番号:
W2549A
ISSN:
1462-8902
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)